Statement der Österreichischen Medizinischen Gesellschaft für Neuraltherapie und Regulationsforschung
zum Thema neuraltherapeutische Therapieoptionen bei Covid-19 Erkrankungen (20.07.2020)

  pdf_download.gif
2020-05-18 | Gerasimos S Papathanasiou | Local Anesthetics and Covid19 Associated Acute Respiratory
Distress Syndrome: A New Therapeutic Indication?
  pdf_download.gif
 2020-06-01 | Ziad A. Ali, Rif S. El-Mallakh | Nebulized Lidocaine in COVID-19, An Hypothesis   pdf_download.gif

 2020-07-23 | Cylan T. Finnerty, Donal J. Buggy | A novel role for lidocaine in COVID 19 patients?

  pdf_download.gif

 2020-11-02 | University Hospital, Strasbourg, France | Impact of Intravenous Lidocaine on Clinical Outcomes
of Patients With ARDS During COVID-19 Pandemia (LidoCovid)

  pdf_download.gif
19-11-2020 | Maria Ayeza Diaz-Vera, José Terrones Santa Cruz, Aldo Forttini Headrington, Javier A Cerna Paz, Luis Quintanilla Rios, Moises P Medina Melendez, José Del Aguila Torres | Lidocaine to reduce the severity of COVID-19 cases    
Veranstaltungen

18 Jun 2021
    Referententreffen

02 Jul 2021
    ICMART Kongress 2021

01 Okt 2021
    Gemeinsame Jahrestagung der IMAK